Key points are not available for this paper at this time.
Medication quality control in Nigeria faces multifaceted challenges rooted in regulatory inefficiencies, infrastructural limitations, and systemic inadequacies. This study undertakes a comprehensive analysis of these challenges while proposing pragmatic solutions to bolster the quality control framework in the Nigerian pharmaceutical sector. Drawing upon extensive literature review and expert insights, the research identifies key regulatory challenges impeding effective medication quality control in Nigeria. These challenges encompass inadequate regulatory capacity, inconsistent enforcement mechanisms, rampant substandard and counterfeit medications, and limited access to essential medicines. Additionally, infrastructural deficiencies such as inadequate laboratory facilities and insufficient human resources further exacerbate the problem, leading to compromised patient safety and public health risks. In response to these challenges, the study proposes a multifaceted approach to enhance medication quality control in Nigeria. This includes strengthening regulatory frameworks through legislative reforms aimed at bolstering enforcement capabilities and harmonizing standards with international best practices. Moreover, improving regulatory capacity through training programs and investment in state-of-the-art laboratory infrastructure is essential to enhance surveillance and detection of substandard medications. Furthermore, fostering collaboration between regulatory agencies, healthcare providers, and pharmaceutical manufacturers is imperative to streamline supply chains and ensure the integrity of medications from production to distribution. Additionally, public awareness campaigns and community engagement initiatives play a pivotal role in empowering consumers to make informed decisions and report instances of substandard medications. By addressing these regulatory challenges and implementing comprehensive solutions, Nigeria can significantly enhance medication quality control, safeguard patient health, and foster a conducive environment for pharmaceutical innovation and growth. Keywords: Medical, Medication, Drugs, Quality Control, Nigeria, Regulations, Review.
Eruaga et al. (Sun,) studied this question.